Biolife Solutions
BLFS
Biolife Solutions (BLFS) - P/B ratio
P/B ratio as of May 2024 : 2.35
According to Biolife Solutions
's latest financial reports the company has a price-to-book ratio of 2.35.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Biolife Solutions - P/B ratio (from 2001 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 2.17 | 1.44% |
| 2022-12-31 | 2.14 | -34.18% |
| 2021-12-31 | 3.25 | -48.97% |
| 2020-12-31 | 6.36 | -17.95% |
| 2019-12-31 | 7.75 | -49.15% |
| 2018-12-31 | 15.2 | 88.17% |
| 2017-12-31 | 8.10 | 23.73% |
| 2016-12-31 | 6.55 | 139.05% |
| 2015-12-31 | 2.74 | 92.66% |
| 2014-12-31 | 1.42 | -144.67% |
| 2013-12-31 | -3.18 | 67.79% |
| 2012-12-31 | -1.90 | 508.9% |
| 2011-12-31 | -0.3116 | -22.36% |
| 2010-12-31 | -0.4013 | -59.02% |
| 2009-12-31 | -0.9793 | 142.39% |
| 2008-12-31 | -0.4040 | -76.11% |
| 2007-12-31 | -1.69 | -106.81% |
| 2006-12-31 | 24.8 | -33.09% |
| 2005-12-31 | 37.1 | 1935.36% |
| 2004-12-31 | 1.82 | 81.02% |
| 2003-12-31 | 1.01 | -137.46% |
| 2002-12-31 | -2.69 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Celanese CE | 2.28 | -2.71% | 🇺🇸 USA |
 Enanta Pharmaceuticals
ENTA | 1.50 | -36.25% | 🇺🇸 USA |
 Amyris AMRS | -0.0285 | -101.22% | 🇺🇸 USA |